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The response of B cells to mitogen includes three phases : Entry into the cell
cycle, Go to G, transition ; DNA synthesis and cell division ; and Ig secretion (1,
2) . There is evidence that T cells can influence each of these phases . T cell
effects have been most easily studied with anti-Ig as the polyclonal stimulus (3,
4) . When small B cells are incubated with anti-1g, a large fraction enlarge and
show increased levels of RNA (5, 6) . The T cell product, B cell stimulatory
factor 1 (BSF-1)' or IL-4, may be an important costimulant that prepares the
anti-Ig-stimulated B cell to enter S phase (7-10) . IL-4 also induces the B
lymphoblast to secrete IgG1 (10, 11) . Other lymphokines, distinct from IL-4,
will induce anti-Ig and dextran sulfate-primed B cells to show increased prolif-
erative and secretory activity (12-17) .
To further understand the contributions of T cells, we have divided the
polyclonal anti-Ig response into two experimental phases : The formation of B
lymphoblasts and their subsequent growth and Ig secretion . We report on a
pathway of lymphoblast development that originates from homogeneous popu-
lations of small, resting, mouse spleen B cells and does not require T cells or the
T cell product IL-4 . The subsequent capacity of these blasts to proliferate and
secrete Ig is, however, critically dependent on lymphokine(s) distinct from IL-1,
-2, -3 and -4 .
Materials and Methods
Animals.
￿
8-20-wk-old CD2F1 (Charles River Breeding Laboratories, Inc ., Wilming-
ton, MA) or BALB/c (Cumberland Farms, Clinton, TN) female mice were used routinely .
C3H/Hej and C3HeB/Fej female mice were from The Jackson Laboratory, Bar Harbor,
ME.
Antibodies. Anti-Thy-1 .2 mAb (IgMK) was partially purified by ammonium-sulfate
precipitation of culture supernatant from HO-13.4 hybridoma cells obtained from the
AmericanType Culture Collection(ATCC, TIB 99, Rockville, MD) . Culture supernatants
from C3PO and HO-2.2 (ATCC TIB 150) were used as sources of cytotoxic anti-Lyt-1 .2
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`Abbreviations used in this paper:
￿
BCGF-II, B cell growth factor II ; BSF-1/IL-4, B cell stimulatory
factor (or IL-4) ; Sn, cell-free conditioned medium or supernatant.
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and anti-Lyt-2.2, respectively. Affinity-purified goat anti-mouse IgD (anti-6) and goat
anti-mouse IgM (anti-,u) were the generous gift of Dr. E. S. Vitetta (University of Texas
Health Science Center, Dallas, TX). Affinity-purified goat anti-mouse IgM (anti-IA, j
chain-specific) and goat anti-mouse Ig (GAM Ig, heavy and light chain-specific) were
purchased fromJackson Immunoresearch (Avondale PA), and anti-IgGI was from South-
ern Biotechnology Associates, Inc. (Birmingham, AL). Coupling of these antibodies to
CNBr-Sepharose CL4B (Pharmacia Fine Chemicals, Piscataway, New Jersey) was accom-
plished at a ratio of 1 mg protein per 1 ml packed, swollen resin according to the method
recommended by the manufacturer. The mAb I IBI I (18) was generously provided by
Dr. W. E. Paul (National Institutes of Health, Bethesda, MD) and affinity purified on
anti-rat Ig immunoadsorbent. Culture supernatant from the B21 .2 hybridoma was used
as a source of anti-I-A (19).
B Cell Preparations. T-depleted spleen cells (hereafter referred to as B cells) were
routinely prepared by treating total splenic white cells with a cocktail of antibodies
directed against Thy-1 .2, Lyt-1 .2, and Lyt-2.2 followed by complement (C) lysis (baby
rabbit complement; Pel-Freeze Biologicals, Rogers, AR) or anti-Thy-1 .2 and C. The T-
depleted cell population was not responsive to 5 fig/ml Con A as measured by [8H]TdR
incorporation at 72 h of culture (data not shown). Adherent cells were depleted by one
or two Sephadex G-10 passages as indicated (20).
Preparation ofAnti-IgBlasts.
￿
Anti-Ig blasts were prepared by culture of B cells at 1-2
X 106/ml with 5,ug/ml anti-Ig-coupled Sepharose for 48-72 h in Hepes-buffered RPMI
1640 (Gibco Laboratories, Grand Island, NY) supplemented with 2 mM glutamine, 100
Ag/ml penicillin, 100 ,ug/ml streptomycin, 10 wg/ml gentamycin, 50 ,,M 2-ME, 5 or 10%
vol/vol heat-inactivated FCS (KC Biological Inc., Lenexa, KA or Gibco Laboratories) in
a humidified 7% C02 environment at 37°C. Anti-Ig blasts were isolated free ofSepharose
beads by centrifugation through Ficoll-Paque (Pharmacia Fine Chemicals). Cells and beads
in a volume of 3-5 ml were layered on a cushion of 3-4 ml Ficoll-Paque, and centrifuged
at 400 gfor 10-15 min. Viable cells (freeof Sepharose beadsand dead cells) were collected
from the interface and washed extensively in a balanced salt solution before reculture in
200 jul microcultures with bacterial LPS (Salmonella typhimurium; Difco Laboratories Inc.,
Detroit MI) or lymphokines from activated T cells.
Density Fractionation of B Cells and Blasts.
￿
Percoll (Pharmacia Fine Chemicals) was
made isotonic with IOX concentrated PBS. Fractions of density 1 .09 g/ml, 1 .085 g/ml,
1 .08 g/ml, 1 .075 g/ml, 1 .065 g/ml, and 1 .055 g/ml were prepared with isotonic Percoll
and PBS. Unstimulated or stimulated (Sepharose-anti-Ig) cells were resuspended in the
1 .075 g/ml layer. 2-ml fractions were layered in a 15-ml conical tube (Sarstedt, Inc.,
Princeton, NJ, or Falcon Labware, Oxnard, CA) and centrifuged for 30 min at 800 g.
High-density B cells were those harvested from bands that formed above the 1 .09 g/ml
and 1 .085 g/ml layers. >90% of the Sepharose-anti-Ig-stimulated cells (blasts) were
collected from bands at 1 .065 g/ml and 1 .075 g/ml. Total cells loaded on each gradient
varied from 0.8-2 X 108 viable B cellsor blasts.
Preparation of Lymphokine-enriched Supernatants.
￿
Supernatants from activated EL-4
thymoma cells were collected 24-48 h after treating the cells with 20 ng/ml PMA (Sigma
Chemical Co., St. Louis, MO). Supernatants were concentrated (5-10-fold) and partially
purified by ammonium-sulfate precipitation as previously described (21). Alternatively
phorbol dibutyrate (PDBU, Sigma Chemical Co.)-induced EL-4 supernatant was prepared
under serum-free conditions as previously described (11, 22).
Recombinant Lymphokines. Recombinant lymphokines were generously provided as
follows: Murine IL-1 by Dr. P. Lomedico (Hoffman-La Roche, Nutley, NJ); human IL-2
by Dr. S. Rudnick (Biogen, Cambridge, MA); murine IL-3 by Dr. Yokata (DNAX, CA);
and murine IL-4 (BSF-1) Dr. T. Mossman (DNAX).
Assays ofAnti-Ig Lymphoblast Function.
￿
Proliferation in response to recombinant lym-
phokines, EL-4 cell-free conditioned medium (EL-4 Sn) or LPS was assayed by reculturing
48-72-h blasts prepared as described above with lymphokine-containing supernatants or
LPS. The cell density, length of incubation, and concentrations of stimuli were varied as
indicated in the Results.508
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Cell density
TABLE I
EL-4 Sn Does Not Induce Growth or IgM Secretion ofHigh-density B Cells
['H]TdR uptake
￿
IgM secretion
Nothing
added
￿
added EL-4 Sn
￿
LPS
Nothing
EL-4 Sn
￿
LPS
gm/ml
￿
cpm x 10-'
￿
ng/ml
>1 .08 1 .0±0.6 0.5±0.2 1 .1±0.2 0 49±20 194±27
<-1 .075 3.9±0.4 24.6±6.8 64 .4±8.8 40±8 836±171 1914±203
Freshly isolated splenic B cells were fractionated on dense Percoll gradients and cultured at 2 x
105/ml alone or with 5 kl EL-4 Sn or 20 ag/ml LPS for 48 h then pulsed overnight with 0.5 ACi
['H]thymidine or culture supernatants harvested at 78 h and assayed for IgM.
Detection ofIg Secretion.
￿
IgM and IgGI in culture medium were measured by RIA as
previously described (11).
FRCS Analysis.
￿
Cells were incubated with 2,ug/ml FITC-conjugated goat-anti-mouse
Ig (Scandic, Vienna, Austria), anti-I-A (clone B21-2), or mouse anti-rat Ig (Boehringer
Mannheim Biochemicals, Indianapolis, IN) as a control for 60 min at 4°C then washed in
PBS and fixed in formalin. Forward light scatter and fluorescence were analyzed on a
Becton Dickinson & Co. (Mountain View, CA) FAGS 440 at the New York Blood Center,
New York.
Cytospin Preparations.
￿
Cells were resuspended at 2-5 x 105/ml in complete medium
and 200 I1 were spun onto slides in a cytocentrifuge (Shandon Southern Instruments Inc.,
Sewickley, PA). Samples were air dried, treated with acetone for 10 min at room
temperature, and air dried again. Samples were stained with FITC-GAM Ig to detect
mouse Ig or FITC-MAR Ig as a control. Samples were preserved in glycerol/PBS and
photographed on a Labophot (Nikon Inc., Garden City, NY) equipped with epifluores-
cence.
Results
High-density B Cells Do not Proliferate or Secrete IgM when Cultured with Activated
T Cell-conditioned Medium. Bulk populations of splenic B cells contain stimu-
lated and unstimulated populations that can be separated on the basis ofdifferent
buoyant densities (5). Low-density B cells (5_1 .075 g/ml in Percoll gradients)
from freshly isolated spleen respond vigorously to LPS or EL-4 Sn and have
presumably been preactivated in vivo (12-14; Table 1) . However, small, high-
density, resting B cells (>1 .080 g/ml) exhibit little proliferation or IgM secretion
when cultured in the presence of T cell-conditioned medium (12-14; Table 1).
Therefore, we used such small resting B cells, isolated by Percoll density gradient
centrifugation, as a more homogeneous starting population to generate B lym-
phoblasts in vitro .
Phenotype and Physical Properties of High-density B Cells and Anti-Ig
Blasts. Stimulation of purified high-density B cells with Sepharose-anti-Ig fol-
lowed by flotation on Ficoll-Paque and Percoll, provided highly enriched popu-
lations of B lymphoblasts. The density and size of the anti-Ig blasts generated in
vitro (as described in Materials and Methods) were compared with freshly isolated
high-density spleen B cells. >90% of recovered cells were found in low-density
fractions of 1 .075 and 1 .065 g/ml . This fraction contained all of the EL-4 Sn-
responsive cells (data not shown). Forward light scatter profiles, which provided
an approximation of cell size, clearly distinguished most high-density B cells fromU
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FACS analysis of small resting B cells and anti-Ig blasts. Freshly isolated splenic
B cells (p > 1.08 g/ml [a-d]) or 3-d anti-Ig blasts (p < 1 .065 g/ml [e-h]) were fixed in 3.7%
formalin and examined on the FACS 440 . Forward light scatter profiles (a and e) and
fluorescent distribution are shown . The cells were stained before fixation for 1 h at 4°C with
FITC-conjugated goat anti-mouse Ig (b and f), anti-I-A (c and g), or mouse anti-rat Ig as a
negative control (d and h) .
most anti-Ig blasts (Fig . 1, a and e). The homogeneity of the population was
further evidenced by the fact that all cells were slg' and I-A rich (Fig. 1) .
Experimental Parameters Influencing the Generation of Anti-Ig-induced Lympho-
blasts.
￿
Anumber of variables were tested for their effect on the yield ofB blasts
generated in response to anti-Ig-Sepharoseand the responsiveness of these blasts
to EL-4 Sn or LPS. The yield and responsiveness of blasts was not significantly
affected by any of the following variables pertaining to the input population of
B cells (Table 11) : (a) The buoyant density of the B cells (Exp . 1) ; (b) adherent-
cell depletion (Exp . 3) . The use ofSephadex G10 depletes most splenic dendritic
cells and macrophages, so that these accessory cells do not seem essential for the
anti-Ig response ; or (c) surface IgM- (sIgM) versus slgD-mediated activation (Exp .
2) . Anti-,u and anti-b were equivalent in stimulating entry into cell cycle and
responsiveness to T cell factors, although somewhat less effective than anti-Ig
(Table 11, Exp . 2) .
Role ofBSF-1 in the Generation ofAnti-Ig Blasts.
￿
The results described above
were obtained with a starting population of T-depleted spleen cells. As indicated
in Fig . 1, the B cells and anti-Ig blasts were >95% Ig+ . In addition, neither the
starting population nor the resulting anti-Ig blasts contained Thy-1' or Lyt-1+
T cells detectable by immunofluorescence (data not shown) . Previous results (7,
9) have, however, suggested animportant role for theTcell-derived lymphokine
BSF-1 forBcell responses to anti-Ig. To address whether the production of BSF-
1/IL-4 by contaminating T cells (or other cell types) during the primary culture
contributed to the response observed, we prepared anti-,u blasts in the presence
of an mAb (11B11) that neutralizes BSF-1 activity (18) . A concentration of
11B11 mAb wasadded that completely inhibited the induction ofIgG 1 secretion
(see below), another BSF-1-dependent response . In several experiments, similar
yields of blasts were obtained from control anti-)-activated cultures and cultures
stimulated in the presence of anti-BSF-1 mAb (Table III) . Blasts were then
cultured with LPS or EL-4 Sn and assayed for proliferation and IgM secretion .510
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TABLE 11
Yield and Response ofAnti-Ig Blasts Made under Various Conditions
In all experiments, 2 x 108 viable B cells/ml were cultured for 48-72 h with Sepharose anti-Ig.
Blasts were recultured at 2 x 105/ml in a total volume of 200 tcl. Viable cell recovery per 108
input cellswasdetermined by counting in the presence of trypan blue.
* Number ofcellsrepresented is the number recovered before centrifugation through Ficoll-Paque,
except forexperiments marked by asterisk, where the numbers shownare final yield of cells.
$ LPS was addedat 10 ug/ml.
¢ EL-4 Sn wasaddedat 1% vol/vol.
I T-depleted and G-10-passed B cells were fractionated on discontinuous Percoll gradients as
described in Materialsand Methods. Cellsfrom each fraction were cultured with Sepharose-anti-
Ig for 72 h. Densitiesare of thecells seeded in the culture.
' Bcells were cultured for 72 h with Sepharose-anti-Ig, -anti-ja, or -anti-3.
** Bcellsdepleted of Tcells or T and adherent cell depleted by two Sephadex G-10 passages, were
cultured with anti-Ig Sepharose for 72 h.
As shown in Table III, blasts prepared in the presence of anti-BSF-1 were
functionally indistinguishable from control blasts.
In three experiments, we found that the preparation of anti-Ig blasts from T-
and adherent cell-depleted splenic B cells in the presence of 100 U/ml of rIL-4
(BSF-1) resulted in a twofold greater yield of blasts on day 3 but had no effect
on their subsequent growth or IgM secretion when stimulated with EL-4 or LPS
(Table III).
We conclude that BSF-1 is not essential for the generation ofB lymphoblasts
from Sepharose-anti-Ig-stimulated mouse spleen B cells.
The Proliferation and Ig Secretion of Anti-Ig Blasts.
￿
The majority of blasts did
not survive in secondary cultures in the absence ofexogenous stimuli. However,
in the presence of lymphokines the number ofviable cells recovered at 20-24 h
ofculture was 150-200% ofthe numberofcells seeded in the secondary culture.
Since B cells would not have divided more than once in this time period, a 1.5-
2-fold recovery signifies the division of at least 50% of the blasts. The rapid
nature of this response was also apparent when [sH]TdR incorporation was
measured at different times (Table IV). When the kinetics of the response of
small B cells and anti-Ig blasts to LPS were compared, anti-Ig blasts responded
much more rapidly (Fig. 2). Detectable responses were observed by 12 h of
culture and approached a maximal value by 24-48 h. In contrast, small B cell
Response of blasts to secondarystimuli
Exp. Cellsused to Cells (['H]TdR incorporation)
prepare blasts* recovered
x 10-5
None LPS$
cpm x 10-1
EL-4 SO
1*J Unfractionated 2.4 6.9 ± 0.1 149 ± 9.0 18.6 ± 1.8
1.85g/ml 1.7 2.9±0.2 81.8±1 .9 10.6±0.5
1.080 g/ml 3.2 3.1 ± 0.4 100.7 ± 12.1 10.3 ± 0.7
1.075 g/ml 3.6 3.6 ± 2.1 100.9 ± 18.1 14.9 ± 1.1
2*-' anti-Ig 13.0 1.1 ± 0.5 93.7 ± 6.4 28.3 ± 0.7
anti-A 4.9 1.5±0.3 82.4±8 .5 22.4±1 .8
anti-S 4.4 2.0 ± 0.4 66.5 ± 4.5 30.2 ± 1.8
3** T-depleted 8.8 2.9 ± 1.1 168.5 ± 17.2 25.5 ± 0.1
T and G10-depleted 9.4 1.5 ± 0.6 152.1 ± 24.4 19.0 ± 1.9BIRKELAND ET AL.
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TABLE III
Response of Anti-Ig Blasts Made in the Presence of
Monoclonal Anti-BSF-1
Splenic B cells(2 X 106/ml) were cultured for 2 (Exp. 1) or 3 (Exps. 2 and
3) d with GAM-Ig Sepharose, and in the presence of 1 wg/ml of a control
monoclonal rat antibody (Exp. 1), or medium (Exps. 2 and 3), or 11B11
anti-BSF-1, or 100 U/ml rBSF-1 . Blasts were isolated as outlined in
Materials and Methods and recultured in microtiter plates at 2 X 10'/ml
for 72 h(Exp. 1) or 48 h (Exp. 2). The yield of blasts in Exp. 1 was 13 X
105 and 12 X 105per 106 inputcells forcontrol blasts andblasts made in
the presence of anti-BSF-1, respectively. ['HJTdR was added during the
last 16 h (Exp. 1) or 8 h (Exps. 2 and 3) of culture andthe concentration
of IgM in the 3-d culture medium wasdetermined by RIA.
responses were not detectable until 24 h and were not maximal until 48 h (Fig.
2). These findings indicate that anti-Ig blasts are poised to enter S phase when
challenged with a mitogenic stimulus.
The proportion ofanti-Ig blasts that were induced by lymphokines to synthe-
size IgM was also remarkable (Fig. 3). The starting population of small B cells
had low levels ofIg, as detected by FITC-goat anti-mouse Ig staining ofcytospin
preparations. At 3 d, anti-Ig blasts were larger and had patches of perinuclear
anti-Ig stain. The vast majority of blasts restimulated with EL-4 Sn stained
brightly for cytoplasmic Ig.
Exp. Addition to
primary culture
Addition to
secondaryculture
['HJTdR
mcorpora-
tion
IgM
cpm X 10' fag/ml
1 Control None 1.6 0.02
LPS 68 .6 0.40
EL-4 Sn (1 ul) 49.4 0.45
EL-4 Sn (5 ,al) 90.5 1.19
Anti-BSF-1 None 0.8 0.03
LPS 83 .3 0.46
EL-4 Sn (1 Al) 35 .1 0.32
EL-4 Sn (5 jil) 129.7 0.90
2 Control None 2.6
LPS 88.6
EL-4 Sn (1 gl) 27 .3
EL-4 Sn (5 ,0) 42 .8
Anti-BSF-1 None 2.7
LPS 133.4
EL-4 Sn (I ul) 34.6
EL-4 Sn (5 jAl) 51 .0
3 Control None 1.6
LPS 116.2
EL-4 Sn (2,ul) 22 .1
Anti-BSF-1 None 1.2
LPS 127.5
EL-4 (2 pl) 12.5
rBSF-1 None 2.7
LPS 113.8
EL-4 Sn (2,ul) 30.251 2
40
X
d
U
0
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TABLE IV
Effect ofEL-4 on Anti-IgBlast Proliferation andIgMSecretion
72-h anti-Ig blasts were prepared from splenic B cells and isolated as described
in Materialsand Methods. Cells were recultured with EL-4 Sri in a final volume
of 200 Al. ['H]TdR wasadded during the last 8 h of culture.
12 24 36
Time (hours)
FIGURE 2.
￿
Kinetics of the LPS response of small B cells and
anti-Igblasts. 72-h anti-Igblasts (0)or T-depleted splenic white
cells (O) were prepared as described and cultured in a final
volume of 200AI with 20 Ag/ml LPS at a density of 105cells/ml
and 5 X 10' cells/ml, respectively. Cultures were pulsed with
0.5 ACi ['H]TdRper well for 4 hat the indicated times.
Severalvariables in the response ofanti-Ig blasts were assessed. Thestimulation
indices of [sH]TdR incorporation and IgM secretion for each dose of EL-4 Sri
remained approximately the same for each cell concentration we tested (Table
IV). This suggests that a constant proportion ofthe blasts respond over a range
ofcell densities. In view of the sensitivity ofanti-Ig blasts to LPS we tested the
possibility that the EL-4 Sn-induced response was due to contaminating LPS by
comparing the response ofB cells from LPS low-responder mice, C3H/Hej, and
normal responder controls, C3HeB/FeJ. The EL-4 Sn-induced proliferation and
IgM secretion ofB cell blasts were comparable to that ofC3HeB/FeJ mice (data
not shown).
Lymphokine Requirements ofAnti-IgBlasts.
￿
Addition ofanti-IL-4 mAb, 11B11,
did not reduce growth or IgM secretion by blasts stimulated with LPS or EL-4
Cellsper
well
X 10-'
EL-4 Sn
Al
['H]TdR
34 h
cpm
incorporation
58 h
X 10-'
IgM at
72 h
Ag/ml
1 0 0.29±0.08 0.29±0.05
1 1.03±0.05 0.56±0.04
5 2.08±0.15 1.13±0.39
2 0 0.73±0.17 0.58±0.23 0.03±0.01
1 1.92 0.18 1.61 ±0.44 0.18±0.04
5 6.92 ± 0.43 4.32 ± 1.24 0.14 ± 0.03
4 0 1.57±0.14 0.77±0.24 0.09±0.02
1 5.59 ± 0.24 4.01 ± 0.42 0.46 ± 0.08
5 14.87 ± 1.45 10.03 ± 1.86 0.43 ± 0.09
10 0 6.05±0.83 2.10±0.91 0.31 ±0.05
1 18.56+2.52 14.92± 1.85 1.38 ± 0.11
5 12.75±5.87 22.43±2.11 1.45±0.14BIRKELAND ET AL .
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FIGURE 3 .
￿
Phase contrast and cytoplasmic anti-Ig stains of B cells . Cytospins of (a and b)
high-density B cells, (c and d) 3-d anti-Ig blasts, and (e-h) anti-Ig blasts treated for 3 d with El-
4 Sn were stained with FITC-goat anti-mouse Ig (af) or FITC-mouse anti-rat Ig (g and h)
as a control .514 GENERATION AND FUNCTION OF B LYMPHOBLASTS
TABLE V
Effect ofAnti-BSF-1 on [sH]thymidine Incorporation by
Anti-Ig Blasts
Anti-Ig blasts were prepared as described in Materialsand Methods in the
presence of 1 wg/ml IIBI1 anti-BSF-1 . Blast were recultured at 2 x
105/ml for 48 h in the presence of 1 gg/ml isotype-matched control rat
mAbor 11 BI 1 anti-BSF-1, then pulsed with 0.5,uCi/well of['Hlthymidine.
TABLE VI
Effect ofAnti-BSF-1 on IgM and IgGI Secretion ofAnti-Ig Blasts
Anti-,u blasts were prepared as described in Materials and Methods. Blasts were recultured at 2 x
105/ml for 5 d, and IgM and IgG1 in the culture supernatant were measured by RIA. 11BI I anti-
BSF-1 or a control rat mAb was added at a final concentration of 1 Ag/ml during the anti-Ig
stimulation in the primary culture and/or the secondary culture of blasts in the absence of any
additional stimuli (nothing added), 1% vol/vol of EL-4 Sn or 20 Wg/ml LPS.
Sn (Table V). In some experiments (Table VI), blasts were prepared in the
presence ofanti-BSF-1, then washed and recultured with or without anti-BSF-1
in the secondary cultures. Parallel cultures were carried out to 5 d so that
secretion ofIgGl, an IL-4-dependent response, could be assayed. This provided
a positive control for the effectiveness of the anti-BSF-1 added. Again, I IBI I
did not diminish the growth or IgM secretion in response to EL-4 Sn, but
completely abolished the IgG1 response.
Additional experiments compared the EL-4 Sn with recombinant IL-1, IL-2,
or IL-3 as stimuli for the growth ofanti-Ig blasts. Although a small boost in [sH]-
TdR incorporation was detected when all three recombinant lymphokines were
added, the lymphokines clearly did not mimic the growth-promoting activity of
EL-4 culture Sn (Table VII).
Discussion
These studies characterize a pathway of polyclonal B cell development that
begins with a small resting B cell and yields large numbers of proliferating
Primary
11B11
Second-
ary
Nothing
added
IgM secretion
EL-4 LPS Nothing
added
IgG secretion
EL-4 LPS
jug/ml 11g/ml
- - <0.1 15.7 16.1 <0.1 2.1 <0.I
- + <0.1 23.1 13 .4 <0.1 <0.1 <0.1
+ - <0.1 16.4 11 .6 <0.1 1.3 0.1
+ + <0.1 13.1 12.4 <0.1 <0.I <0.1
Exp. 11B11 Nothing
added
['H]TdRincorporation
EL-4 LPS
cpm x 10-'
1 - 1.6 90.5 46.4
+ 0.8 120.6 60.4
2 - 1.3 53.7 88.3
+ 0.7 67.0 103.5BIRKELAND ET AL.
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TABLE VII
Recombinant IL-1, -2, and -3 Do NotMimic the Activity Found in
EL-4 Sn
72-h anti-Ig blasts were prepared as described in Materials and Methods
and recultured at 105cells/well for 15 h. ['H]Thymidine wasaddedat 7-
15 h.
lymphoblasts that secrete IgM. The response to Sepharose-anti-Ig proceeds in
two phases. The formation of large, la-rich blasts, which appears to be T
independent, followed by proliferation and differentiation that is dependent on
factors released by PMA-activated EL-4 thymoma cells. The lymphoblasts de-
scribed in this study provide an excellent model for characterizing the factors
that mediate T-dependent, B cell development.
The Formation of Lymphoblasts in Response to Anti-Ig.
￿
One purpose of these
studies was to define the conditions necessary to generate lymphokine-responsive
blasts from small resting B cells. Sepharose-anti-Ig, -anti-,U, or -anti-3 can all be
used, the cell suspension can be depleted of most macrophages and dendritic
cells by passage over Sephadex G10, and high-density resting B cells are as
responsive as bulk, T-depleted spleen cells (Table II). It is possible that the signal
delivered by Sepharose-anti-Ig differs from that provided by most soluble, T-
dependent antigens. The two stimulation pathways do seem to differ since
Sepharose-anti-Ig induces lymphoblasts that are responsive to lymphokines,
while a period of direct B-T cell contact is required for hapten-carrier conjugates
to induce responsiveness to lymphokines (23).
We have been unable to identify a major role for the T cell product BSF-1 or
IL-4 in the Sepharose-anti-Ig response. IL-4 was discovered on the basis of two
biological activities: as a costimulant for enhanced B cell proliferative responses
to anti-Ig (7) and as a factor that increased switching of LPS-stimulated B cells
to IgG 1 (24). Our data demonstrate that lymphokine-responsive blasts can be
produced and will continue to proliferate in the apparent absence of IL-4. There
are some differences between our experiments and those suggesting a necessary
role of IL-4 in anti-Ig signaling. Other studies (7, 25) have relied on soluble anti-
Ig, which probably differs from Sepharose-anti-Ig in its activation of B cells. For
example, Mond et al. (26) found that stimulation of B cells with soluble anti-Ig
was inhibited by IFN-y, whereas that induced by insoluble anti-Ig was not. The
advantage to using Sepharose-anti-Ig is that it can be effectively removed from
the blasts before reculturing. We also performed our initial cultures at higher
cell concentrations (1-2 X 106 cells/ml), whereas lower cell concentrations have
been used to assess BSF-1 effects (25). However, we obtain marked responses to
Stimuli [sH]TdRincorporation
cpm x 10-'
None 2.61 ± 0.19
LPS 88 .57 ± 12.98
EL-4 Sn 50.13 ± 4.02
rIL-1 (100 U/ml) 4.73 ± 0.25
r1L-2 (100 U/ml) 6.01 ± 1.37
rIL-3 (100 U/ml) 7.57 ± 1.03
r1L-1 + 2 + 3 10.26 ± 0.5651 6
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Sepharose-anti-Ig in low-density microcultures in the presence of monoclonal
anti-BSF-1 (data not shown). Finally, although the phenotype of our initial B
cells provides no evidence for previous activation in situ (high-buoyant density,
small size, low levels of surface Ia), it is possible that the lymphocytes we studied
have had prior contact with BSF-1 .
Characteristics ofLymphoblast Response to LPS and to Lymphokines.
￿
The B blast
that is induced by Sepharose-anti-Ig is poised to synthesize DNA. Within 6-12
h of applying LPS or El-4 Sn, [sH]TdR uptake and cell recoveries increase.
Comparable responses only begin between 24 and 48 h with small resting B cells.
In contrast to the proliferative response to LPS and EL-4 Sn, IgM secretion
by anti-Ig blasts begins at about the same time (48 h) as it does with small B cells.
This suggests that the entry of the lymphoblast into the G, phase is not sufficient
to enable prompt IgM secretion. One or more cell divisions seem to be required.
We have previously noted that IgM secretion by normal and tumor B cells is
reduced when the cells are inhibited from passage through S phase (22).
More detailed cell cycle analyses, as with RNA and DNA binding dyes and
flow cytometry, will be required to accurately determine the proportion of anti-
Ig blasts that continue through the cell cycle. Nevertheless, it is clear that a
substantially greater fraction of anti-Ig blasts respond -to LPS than do bulk spleen
B cells. At least 50% of the B blasts respond to LPS as opposed to a maximum
of 10-30% of fresh spleen B cells under optimal conditions (27, 28). Specifically,
we observed >150% recovery of anti-Ig blasts cultured overnight with either
LPS or EL-4 Sn. Since 24 h is only enough time to permit cells to pass through
one cell cycle, the majority of the blasts (>_50) must have responded. In prelimi-
nary autoradiographic studies, we have noted that all nuclei from anti-Ig blast
cultures become labeled with [sH]TdR after 24 h (data not shown). In addition,
the vast majority of the blasts are producing high levels of IgM after a 3-d
stimulation with EL-4 Sn (Fig. 3) .
Identity ofthe Lymphokine(s) that Influence the Anti-Ig Blast.
￿
Recombinant IL-1,
-2, -3, and -4 (alone or in various combinations) induce little or no proliferative
activity or IgM release from anti-Ig blasts. In contrast, EL-4 Sn is a potent
stimulus. The active material(s) in the EL-4 Sn migrates as a broad peak around
50 kD on gel filtration (data not shown). Similar findings have been reported by
Muller et al . (16), who suggested that the factor was similar to the lymphokine
that costimulates normal B cells with dextran sulfate and was called B cell growth
factor II (BCGF-II) by Swain and coworkers (29, 30). Given the magnitude and
apparent homogeneity of the anti-Ig blast response, it should be feasible to
further characterize the EL-4 Sn and to test new factors derived by molecular
cloning, including the BCGF-II-like gene (31) .
Summary
Sepharose-anti-Ig and purified populations of small, high-density B cells have
been used to study the formation and function of B lymphoblasts. Sepharose-
anti-Ig converts small, Ia-poor B cells with a high-buoyant density to large, la-
rich, B blasts with a low-buoyant density. We find that this response proceeds
efficiently in the absence of IL-4 (BSF-1) as well as most T cells, macrophages,
and dendritic cells. Further development of the blasts requires an additionalstimulus, such as LPS or the conditioned medium of stimulated EL-4 thymoma
cells. Within 6 h, blasts begin to enter S phase and within 24 h most divide. At
later times (48-72 h) most of the blasts are actively secreting IgM. Recombinant
IL-1, -2, -3, and -4 have little or no effect on the B blasts, and a neutralizing
mAb to IL-4 does not block the response to EL-4 Sn . We conclude that
Sepharose-anti-Ig induces B cell blastogenesis in a T-independent fashion and
that these blasts represent a highly enriched population of cells that respond to
distinct, T cell-derived lymphokines.
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